Prescribing pattern of glucose lowering drugs in the United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone

Mar-13

AUTHORS : Dr Miriam Sturkenboom, Julius Global Health, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands – Email: m.c.j.sturkenboom@umcutrecht.nl – Profile: https://www.umcutrecht.nl/en/research/researchers/sturkenboom-miriam-mcjm OR Gianluca Trifirò, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 1, Consolare Valeria Street, 98125, Messina, Italy / Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands – Email: trifirog@unime.it – Profile: https://www.unime.it/it/persona/gianluca-trifir%C3%B2 – Contact Ms Ingrid Leal (Details for study: Erasmus University Medical Center) now works at Janssen but I cannot find her contact details.

JOURNAL : British Journal of Clinical Pharmacology

REFERENCE: 75(3):861-8

DOI : 10.1111/j.1365-2125.2012.04401.x

Prescribing pattern of glucose lowering drugs in the United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study